Financial statements Branq
Balance sheet data of BRANQ
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 50 661 029,39 | 53 831 610,27 | 55 989 494,44 | 66 981 200,15 | 71 733 045,09 | 73 133 229,83 |
| A. Fixed assets | 37 418 339,07 | 39 485 716,90 | 39 943 349,78 | 43 977 466,65 | 46 726 058,15 | 46 118 946,54 |
| B. Current assets | 13 242 690,32 | 14 345 893,37 | 16 046 144,66 | 23 003 733,50 | 25 006 986,94 | 27 014 283,29 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 50 661 029,39 | 53 831 610,27 | 55 989 494,44 | 66 981 200,15 | 71 733 045,09 | 73 133 229,83 |
| A. Equity | 16 964 787,58 | 16 884 994,73 | 22 768 565,25 | 26 252 916,18 | 34 500 115,28 | 38 505 891,23 |
| B. Liabilities and provisions for liabilities | 33 696 241,81 | 36 946 615,54 | 33 220 929,19 | 40 728 283,97 | 37 232 929,81 | 34 627 338,60 |
| I. Long-term liabilities | 15 256 792,43 | 13 218 072,61 | 10 002 319,10 | 10 171 463,84 | 13 029 851,14 | 5 279 093,57 |
| II. Short-term liabilities | 14 643 182,71 | 17 862 424,81 | 16 739 148,38 | 24 917 892,45 | 19 607 768,43 | 25 565 795,26 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD